-
The latest issue of IBO is now available. It features part 1 of our coverage of
#slas2020, our look at#lab tool companies at#jpm2020, news on@abcam,@biotechne and@JEOLUSA and much more https://buff.ly/2RYkN9k -
“The access our clients gained to this broad buy-side audience is a testament not only to our internal network & capital markets experience, but also the quality of our client portfolio.”
@JeffreyG_KCSA on the#JPM2020 Healthcare Conference. http://bit.ly/2RVMZd3#KCSAKnowledgepic.twitter.com/P2OZOoyuvA
-
Accenture, Google hope to lure Big Pharma clients GSK, Pfizer and more to new data platform.
#JPM2020 http://bit.ly/2vFjNhE by@fiercepharma -
Canaccord Genuity analyst Richard Close tallied the most-used buzz words referenced by nonprofit health systems in
#JPM2020 presentations: 1. Partnerships / M&A 2. Post-acute / Ambulatory 3. Quality / Outcomes / Safety 4. Telehealth / Digital Health 5. Affordability / Access -
Did you miss
#JPM2020 last month? Would you like to catch up with all the latest news & views? Click to read all the analysis from our experts who attended the event: http://bit.ly/2trzJmZ pic.twitter.com/kwjyNBm3tq
-
Michael Murphy M.D., Ph.D. provides his perspective on the standout moments from
#JPM2020 in@worldwidetrials latest blog. Read now. http://bit.ly/36Wgkbu pic.twitter.com/KjNuTWpSUY
-
KCSA Managing Partner
@JeffreyG_KCSA recaps our team’s time at the#JPM2020 Healthcare Conference and highlights our clients who are making significant contributions to the overall healthcare system in this blog post: http://bit.ly/2RVMZd3#KCSAKnowledgepic.twitter.com/JVZq3s8Xlx
-
Join us in London for a discussion on the main take-outs and commentary on the deal-making that took place at
#JPM2020. Find out more here: https://onenucleus.com/civicrm/event/info?reset=1&id=1332 …pic.twitter.com/Aaa4ltHL8k
-
This article was written about us in 2017, our first year
@StartupHealth Festival. We have since completed Pre-Clinical Animal Studies with an actual functioning SmartTab and will continue to make advancements in this new decade of innovation!#JPM2020 https://buff.ly/31jUJsh pic.twitter.com/YrOWHUCQgE
-
The
@KCSAstrategic team had a great time at the#JPM2020 Healthcare Conference, and I’m so proud to be working with clients who are making significant contributions to the overall healthcare system. I reflect on the event in this blog post: http://bit.ly/2RVMZd3#KCSAKnowledgepic.twitter.com/UGQ7vVgbTB
-
Following the
#JPM2020 Healthcare Conference, KCSA Managing Partner@JeffreyG_KCSA breaks down the key highlights from the event and the growing opportunities for our clients in the#healthcare space. http://bit.ly/2RVMZd3#KCSAKnowledgepic.twitter.com/6pgsgT2g4K
-
Digital upskilling and using
#emergingtech is a top#workforce priority for#health organizations. Explore the top issues of 2020.#JPM2020#JPM20 http://bit.ly/2vNnQJ1 -
What a week! Bio-Link was delighted to represent our client,
@ActinogenMed, at#JPM2020. We travelled over 31 km (generally on foot) around San Francisco, meeting with leading pharma executives, sharing the latest exciting data and future strategy for the development of#Xanamempic.twitter.com/FZYOXZ2777
-
Two of my favorite ladies in
#healthInnovation. It was great to see you all,@SolomeTibebu and@KisteinM! 2020 is going to bring great things!#tbd#jpm2020#startuphealthpic.twitter.com/4Km0MeIVSz
-
There was one comment we heard at
#JPM2020 that stuck with us: “Humility will win the day.” Surprising, maybe, but a window into a shift happening across our industry. https://hubs.ly/H0mQhH70 -
Check out Nadine's experience at the 38th annual
#JPM2020 Healthcare Conference. From the tech alone, to the “so what?” question. To#patient impact and a#sustainable business model. Read this article to learn more http://ow.ly/BhQm50y8YeP pic.twitter.com/RVuQkqUVuK
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.